11-OXO™-Hormone control breakthrough from ERGOPHARM

ERGOPHARM proudly introduces 11-OXO™, the first selective inhibitor of 11-hydroxysteroid dehydrogenase type I reductase.

Finally, cortisol control that delivers on the promises.

ERGOPHARM has found the key to obtaining:

• Decreased bodyfat (especially visceral adipose tissue)

• Increased muscle density (hardness)

• Enhanced insulin sensitivity and glycogen deposition

• Increased strength

• Improved brain and CNS function

We started the prohormone era... Welcome to day one of the SCM era!